Oorsprong van het eerstegraads netwerk van Cameron Decker
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities.
18
| Private Company | Investment Managers | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Cameron Decker via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| University of Virginia | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| Boston College | College/University | Undergraduate Degree | |
| Texas A&M University | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Connecticut | College/University | Doctorate Degree | |
| University of Georgia | College/University | Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
| University of Oregon | College/University | Undergraduate Degree | |
| University of Vermont | College/University | Undergraduate Degree | |
| International Rett Syndrome Foundation | Director/Board Member | ||
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Pharmaceuticals: Major | Director/Board Member | |
DTx Pharma, Inc.
 DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Sydnexis, Inc.
 Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Sydnexis, Inc. engages in the production of ophthalmic pharmaceutical products. The company was founded by Gregory Isaac Ostrow in 2014 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Indefinite Integral, Inc.
 Indefinite Integral, Inc. Financial ConglomeratesFinance Indefinite Integral, Inc. is a financial services company, which develops monetary contracts based on block chain. The company was founded by James Prestwich and is headquartered in San Francisco, CA. | Financial Conglomerates | Director of Finance/CFO | |
Cerebral Therapeutics, Inc.
 Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Miscellaneous Commercial Services | Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
89Bio Ltd.
 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Part of 89bio, Inc., 89Bio Ltd. is an Israeli company that develops therapies and drugs for the treatment of patients living with nonalcoholic steatohepatitis. The company is based in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Founder Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Analyst | |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Biotechnology | Director/Board Member | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member | |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Forge Biologics, Inc.
 Forge Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Forge Biologics, Inc. operates as a gene therapy development engine, focused on enabling access to life changing gene therapies. The firm is a viral vector gene therapy manufacturing and development company with the dual platform of CDMO capabilities and the development of proprietary gene therapy products. The company was founded by Timothy J. Miller and Jaysson Eicholtz and is headquartered in Columbus, OH. | Miscellaneous Commercial Services | Director/Board Member | |
Kira Pharmaceuticals (US) LLC
 Kira Pharmaceuticals (US) LLC Pharmaceuticals: MajorHealth Technology Part of Kira Pharmaceuticals (Suzhou) Co., Ltd., Kira Pharmaceuticals (US) LLC develops transformative therapies for people with complement-mediated diseases. The company is based in Cambridge, MA. The company was founded by Gonghua Pan, Wenru Song. Frederick C. Beddingfield has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| RESEARCH ALLIANCE CORP. II | Financial Conglomerates | Chief Executive Officer Founder | |
| MINERALYS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
LENZ Therapeutics, Inc.
 LENZ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LENZ Therapeutics, Inc. manufactures pharmaceuticals. The firm sells eye care products. The company was founded by James W. McCollum, Lee Nordan and Gerald Horn and is headquartered in Coronado, CA. | Pharmaceuticals: Major | Director/Board Member | |
| CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Boston University School of Medicine | College/University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Verenigd Koninkrijk | 3 |
| China | 2 |
| Israël | 2 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 18 |
| Finance | 6 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 82 |
| Independent Dir/Board Member | 31 |
| Undergraduate Degree | 18 |
| Analyst-Equity | 17 |
| Doctorate Degree | 12 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter Kolchinsky | 32 |
| Andrew Levin | 21 |
| Derek DiRocco | 17 |
| Raj Shah | 16 |
| Matthew Hammond | 13 |
| Jake Simson | 11 |
| Zach Scheiner | 11 |
| Laura Stoppel | 9 |
| Brian Lewandowski | 4 |
| Drew Biedermann | 3 |
| David Migl | 3 |
| Ross Chikarmane | 3 |
| Katherine Terranova | 3 |
| Sonia Kartha | 2 |
| Peter Balogh | 2 |
- Beurs
- Insiders
- Cameron Decker
- Bedrijfsconnecties
